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We appreciate the interest and comments of Dr. Kim et al. on 
our study, “The prevalence of peripheral arterial disease in Ko-
rean patients with type 2 diabetes mellitus attending a univer-
sity hospital,” which was published in Diabetes & Metabolism 
Journal 2011;35:543-50.
  Peripheral arterial disease (PAD) is a clinical manifestation 
of the atherosclerotic process, which is associated with cardio-
vascular disease (CVD) and increased CVD risk. Several co-
hort studies have shown that a low ankle-brachial index (ABI) 
is a risk factor of fatal and nonfatal coronary heart disease 
(CHD) and all-cause mortality among people with and with-
out clinical CHD [1-3]. 
  The prevalence of PAD is 2- to 4-fold higher in people with 
diabetes mellitus than in the general population [4], and this 
may be due to hyperglycemia, hypertension, hyperlipidemia 
and other factors that are associated with diabetes [5]. Previ-
ous prevalence estimates for PAD from the U.S. and European 
populations with diabetes have ranged from 10% to 42% [6-10]. 
In contrast, the prevalence of PAD in Asian populations has 
been reported to be lower than that in Western populations, 
ranging from 3.0% to 7.6% [11-13]. Dr. Kim et al. asked wheth-
er there is a real ethnic difference because the prevalence of 
PAD in Chinese patients with type 2 diabetes mellitus was re-
ported to be 32.2% [14]. In their study, however, they recruited 
participants not only from the endocrinology division, but also 
from the cardiology division. Thus, there may have been a se-
lection bias; patients with symptomatic CVD could have been 
more participated in their study. To support this possibility, 
they reported 132 deaths among 1,647 participants during the 
13-month follow-up, 47 of which were from CVD [14]. 
  Dr. Kim et al. also pointed out that an ABI >1.4 is usually 
considered abnormal and asked why patients with high-ABI 
are rare in our study. High ABI is due to an increased rigidity 
of the arterial wall of the lower extremities, as can be often ob-
served in diabetic patients with medial calcification [15]. A re-
cent issue from the PARTNER program found positive associ-
ations between high-ABI (>1.4) and diabetes, male gender 
and waist circumference [16]. In our study, only 0.7% of dia-
betic patients had high-ABI. However, it is not clear why these 
high-ABI patients participated in our study in such a low 
prevalence. 
  As also noted by Dr. Kim at al., stiffness of the central arter-
ies plays an important role in the pathophysiology of CVD, 
and pulse wave velocity (PWV) of the aorta has been used as 
the standard measure of central arterial stiffness. However, we 
could not measure aortic PWV, and this is one of the several 
limitations in our study.
  The results of our study showed that the prevalence of PAD 
is quite low in Korean patients with type 2 diabetes in compar-
ison with that in Western countries. Further prospective stud-
ies with larger sample sizes are needed to evaluate the preva-
lence and risk factors of PAD in Korean diabetic patients and 
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to establish the differences among different populations.
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